Form 4: Molina Healthcare EVP Acquires 9,606 Shares

Molina Healthcare's EVP of Medicaid, Debra Bacon, reported the acquisition of 9,606 restricted common shares and the disposition of 716 shares for tax purposes.

Summary

• Debra Bacon, EVP of Medicaid at Molina Healthcare, Inc. (MOH), reported transactions involving the company's common stock.
• On March 1, 2026, 716 shares were disposed of at $154.05 per share to cover withholding taxes related to the vesting of 2,021 shares.
• On the same date, 9,606 shares were acquired as a grant of restricted stock under the Issuer's 2025 Equity Incentive Plan at a volume-weighted average price of $145.75.
• Following these transactions, Debra Bacon beneficially owns 21,796 shares of common stock.
• The newly granted 9,606 shares will vest in one-third increments on March 1, 2027, March 1, 2028, and March 1, 2029.
• Additional shares will vest as follows: 529 shares on July 1, 2026; 1,775 shares on March 1, 2027; and 1,018 shares on March 1, 2028.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting continued executive commitment and a standard component of long-term incentive compensation, which aligns management's interests with shareholder value.

Positives

• Grant of 9,606 restricted shares to a key executive, indicating continued alignment of management interests with shareholders.
• The acquisition price of $145.75 per share for the restricted stock grant is below the closing price of $154.05 used for tax disposition, suggesting a favorable grant valuation.

Negatives

• Disposition of 716 shares for tax withholding, which is a standard procedure but reduces direct ownership.

Future Outlook

The filing details a future vesting schedule for restricted stock grants, with shares vesting in increments on March 1, 2027, March 1, 2028, March 1, 2029, and additional shares vesting on July 1, 2026, March 1, 2027, and March 1, 2028.

Industry Context

StockSavvy.ai notes that executive stock grants are a common practice in the healthcare industry, aligning executive incentives with long-term company performance and shareholder value. This transaction reflects a standard compensation mechanism for senior leadership within a publicly traded healthcare provider like Molina Healthcare.

Comparison to Industry Standards

• StockSavvy.ai observes that the structure of restricted stock grants with multi-year vesting schedules is a standard practice across various industries, including healthcare, for executive compensation.
• Companies like UnitedHealth Group (UNH) and Anthem (ELV) frequently utilize similar equity incentive plans to retain and incentivize key personnel, ensuring their interests are aligned with long-term company growth.
• The specific grant size and vesting terms are typically benchmarked against peer companies to ensure competitive executive compensation.

Related Party Transactions

• The grant of restricted stock to an executive officer (Debra Bacon) is a related party transaction, as it involves a transaction between the company and a key management personnel.
• The disposition of shares for tax withholding is also a related party transaction, as it facilitates the executive's tax obligations arising from company compensation.

Stakeholder Impact

• Shareholders: The grant of restricted stock aligns the executive's long-term interests with shareholder value, potentially leading to more focused efforts on company performance.
• Employees: Reflects the company's executive compensation strategy, which can influence overall employee morale and retention strategies.
• Management: Provides long-term incentives and compensation to a key executive, reinforcing commitment and retention.

Next Steps

• Vesting of 529 additional shares on July 1, 2026.
• Vesting of one-third of 9,606 newly granted shares and 1,775 additional shares on March 1, 2027.
• Vesting of one-third of 9,606 newly granted shares and 1,018 additional shares on March 1, 2028.
• Vesting of the final one-third of 9,606 newly granted shares on March 1, 2029.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation event involving a restricted stock grant and tax-related share disposition. It does not present new information that would fundamentally alter the investment thesis for Molina Healthcare. Investors should continue to hold based on broader company fundamentals and market conditions, as this filing primarily indicates ongoing executive alignment rather than a catalyst for significant price movement.

Keywords

Molina Healthcare, MOH, Debra Bacon, Insider Trading, Form 4, Restricted Stock, Equity Incentive Plan, Executive Compensation, Share Grant, Stock Vesting